See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Nov. 12, 2008

Multiple Sclerosis Chronic Pain Epilepsy

(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:

Multiple Sclerosis

If you are aged 18 to 55, have a confirmed diagnosis of RRMS, have had at least one relapse in the last 12 months or two relapses in the last 24 months, and have never been treated with any interferon medication, you may qualify for this study.

The research site is in Lebanon, N.H.

More information

Please see http://www.centerwatch.com/patient/studies/cat102.html.

-----

Chronic Pain

If you are aged 18 to 80, have had chronic pain for at least three months, are using an opioid drug (e.g. morphine, oxycodone, fentanyl), and have one-to-five breakthrough pain episodes per day, you may qualify for this study.

The research site is in Bloomington, Ill.

More information

Please see http://www.centerwatch.com/patient/studies/cat45.html.

-----

Epilepsy

If you are 65 or older, have been diagnosed with epilepsy, have documented seizure activity, and are currently treated with one or two anti-epileptic drugs, you may qualify for this study.

The research site is in Schenectady, N.Y.

More information

Please see http://www.centerwatch.com/patient/studies/cat62.html.

-----

Copyright 2008 CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.